Christopher Astle

Chief Financial Officer, Zymeworks.

Companies

ZymeworksChief financial officer Dec 14, 2022 to Jan 8, 2024¹
ZymeworksChief financial officer Mar 4, 2022 to Mar 11, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Zymeworks ZYME670 shares³$17.1K at $25.56Mar 4, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 8, 2024Sold 1,431 shares at $11.22 of CIK 1937653⁴
Jan 5, 2024Sold 4,563 shares at $10.65 of CIK 1937653⁴
Jan 5, 2024Exercised options 10,500 shares of CIK 1937653⁴
Dec 11, 2023Sold 886 shares at $9.13 of CIK 1937653⁵
Dec 11, 2023Exercised options 1,550 shares of CIK 1937653⁵
Dec 12, 2022Sold 887 shares at $6.01 of CIK 1937653⁶
Dec 12, 2022Sold 887 shares at $6.01 of CIK 1937653⁷
Dec 12, 2022Exercised options 1,550 shares of CIK 1937653⁶
Dec 12, 2022Exercised options 1,550 shares of CIK 1937653⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZymeworks, Chief financial officer
2
SEC EDGARZymeworks, Chief financial officer
3
SEC EDGARZymeworks shares after the filing of Mar 4, 2022
4
SEC EDGARForm 4 filed Jan 8, 2024
5
SEC EDGARForm 4 filed Dec 11, 2023
6
SEC EDGARForm 4 filed Dec 23, 2022
7
SEC EDGARForm 4 filed Dec 14, 2022